Other studies have also reported a higher serum sPD-L1 concentration in patients with metastasis [29, 31, 33, 34, 37], suggesting that a high level of sPD-L1 is beneficial for tumor escape from immune surveillance [15]. Here, SPDL1 is linked to neoplasm.